Invitae announced that it is acquiring Good Start Genetics and CombiMatrix under deals that add reproductive health testing products to its offerings. Separately, Invitae plans a private placement of $73.5 million of stock.
Invitae announces $73.5M stock sale, acquisitions of Good Start, CombiMatrix
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.